Scientists at Google DeepMind have developed an AI program called AlphaMissense.
It can predict the potential harm or harmlessness of genetic mutations, particularly missense mutations that involve single-letter changes in the DNA code.
These mutations can lead to disorders such as cystic fibrosis, cancer, and brain development issues.
AlphaMissense assessed 71 million single-letter mutations in human proteins.
It achieved a 90% precision rate, categorizing 57% as likely harmless and 32% as potentially harmful, leaving some uncertainty.